Thomas A. Faunce

Journal article

Policy challenges from the 'White' Senate inquiry into workplace-related health impacts of toxic dusts and nanoparticles

On 22 June 2005 the Senate of the Commonwealth of Australia voted to establish an inquiry into workplace harm related to toxic dust and emerging technologies (including nanoparticles). The inquiry became known as the White Inquiry after Mr Richard White, a financially uncompensated sufferer of...

A backdoor to higher medicine prices? Intellectual property and the Australia-US Free Trade Agreement

Recent comments by Australian negotiators indicate that the US is seeking changes to Australia's intellectual property laws, particularly as they relate to pharmaceuticals. Such changes have the capacity to undermine the effectiveness of the pharmaceutical benefits scheme and lead to higher costs in Australia. Buddhima...